DOI: 10.1055/s-00000054

Pharmacopsychiatry

Issue 03 · Volume 54 · May 2021 DOI: 10.1055/s-011-50840

Original Paper

  • 101
    Petermann, Markus; Kronenberg, Golo; Mosienko, Valentina; Bader, Michael; Alenina, Natalia; Hellweg, Rainer; Klempin, Friederike:

    Alterations in BDNF Protein Concentrations in the Hippocampus do not Explain the Pro-Neurogenic Effect of Citalopram on Adult Neurogenesis

  • 106
    Kato, Hideo; Koizumi, Teruki; Takeuchi, Hiroyoshi; Tani, Hideaki; Mimura, Masaru; Uchida, Hiroyuki:

    Effects of Discontinuation of Drugs Used for Augmentation Therapy on Treatment Outcomes in Depression: A Systematic Review and Meta-analysis

    Supplementary Material (PDF)
  • 117
    Fekete, Stefanie; Scherf-Clavel, Maike; Gerlach, Manfred; Romanos, Marcel; Kittel-Schneider, Sarah; Unterecker, Stefan; Egberts, Karin:

    Dose-Corrected Serum Concentrations and Metabolite to Parent Compound Ratios of Venlafaxine and Risperidone from Childhood to Old Age

    Supplementary Material (PDF)
  • 126
    Bohlken, Jens; Riedel-Heller, Steffi; Bauer, Michael; Kostev, Karel:

    Bipolar Disorder and Outcomes of Monotherapy with Lithium, Valproate, Quetiapine, Olanzapine, Venlafaxine, and Citalopram

  • 131
    Hao, Yong; Tong, Yingpeng; Guo, Yanhong; Lang, Xiaoe; Huang, Xinxin; Xie, Xiaoxian; Guan, Yangtai; Li, Zezhi:

    Metformin Attenuates the Metabolic Disturbance and Depression-like Behaviors Induced by Corticosterone and Mediates the Glucose Metabolism Pathway

    Supplementary Material (PDF)

    • Letter to the Editor

  • 142
    Bonnet, Udo; Juckel, Georg; Scherbaum, Norbert; Schaefer, Martin; Kis, Bernhard; Cohen, Simon; Kuhn, Jens:

    Are Persons Treated with Antidepressants and/or Antipsychotics Possibly Better Protected against Severe COVID 19?